Literature DB >> 25568439

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers.

Hosam M Zowawi1, Anna L Sartor2, Hanna E Sidjabat2, Hanan H Balkhy3, Timothy R Walsh4, Sameera M Al Johani5, Reem Y AlJindan6, Mubarak Alfaresi7, Emad Ibrahim8, Amina Al-Jardani9, Jameela Al Salman10, Ali A Dashti11, Khalid Johani12, David L Paterson2.   

Abstract

The molecular epidemiology and mechanisms of resistance of carbapenem-resistant Acinetobacter baumannii (CRAB) were determined in hospitals in the states of the Cooperation Council for the Arab States of the Gulf (Gulf Cooperation Council [GCC]), namely, Saudi Arabia, United Arab Emirates, Oman, Qatar, Bahrain, and Kuwait. Isolates were subjected to PCR-based detection of antibiotic resistance genes and repetitive sequence-based PCR (rep-PCR) assessments of clonality. Selected isolates were subjected to multilocus sequence typing (MLST). We investigated 117 isolates resistant to carbapenem antibiotics (either imipenem or meropenem). All isolates were positive for OXA-51. The most common carbapenemases were the OXA-23-type, found in 107 isolates, followed by OXA-40-type (OXA-24-type), found in 5 isolates; 3 isolates carried the ISAba1 element upstream of blaOXA-51-type. No OXA-58-type, NDM-type, VIM-type, or IMP-type producers were detected. Multiple clones were detected with 16 clusters of clonally related CRAB. Some clusters involved hospitals in different states. MLST analysis of 15 representative isolates from different clusters identified seven different sequence types (ST195, ST208, ST229, ST436, ST450, ST452, and ST499), as well as three novel STs. The vast majority (84%) of the isolates in this study were associated with health care exposure. Awareness of multidrug-resistant organisms in GCC states has important implications for optimizing infection control practices; establishing antimicrobial stewardship programs within hospital, community, and agricultural settings; and emphasizing the need for establishing regional active surveillance systems. This will help to control the spread of CRAB in the Middle East and in hospitals accommodating transferred patients from this region.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25568439      PMCID: PMC4390656          DOI: 10.1128/JCM.02784-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Acinetobacter baumannii: emergence of four strains with novel bla(OXA-51-like) genes in patients with diabetes mellitus.

Authors:  A A Alsultan; A Hamouda; B A Evans; S G B Amyes
Journal:  J Chemother       Date:  2009-06       Impact factor: 1.714

2.  Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saudi Arabia: a 6-year retrospective cohort study.

Authors:  H H Balkhy; M S Bawazeer; R F Kattan; H M Tamim; S M Al Johani; F A Aldughashem; H A Al Alem; A Adlan; L A Herwaldt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-05       Impact factor: 3.267

3.  Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit.

Authors:  Marco Dettori; Andrea Piana; Maria Grazia Deriu; Paola Lo Curto; Andrea Cossu; Rosario Musumeci; Clementina Cocuzza; Vito Astone; Maria Antonietta Contu; Giovanni Sotgiu
Journal:  New Microbiol       Date:  2014-04-01       Impact factor: 2.479

4.  Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.

Authors:  Jennifer M Adams-Haduch; Ezenwa O Onuoha; Tatiana Bogdanovich; Guo-Bao Tian; Jonas Marschall; Carl M Urban; Brad J Spellberg; Diane Rhee; Diane C Halstead; Anthony W Pasculle; Yohei Doi
Journal:  J Clin Microbiol       Date:  2011-09-14       Impact factor: 5.948

5.  Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Authors:  L Poirel; T Naas; D Nicolas; L Collet; S Bellais; J D Cavallo; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

7.  Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait.

Authors:  Rémy A Bonnin; Vincent O Rotimi; Mona Al Hubail; Elise Gasiorowski; Noura Al Sweih; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

8.  Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia.

Authors:  Aiman El-Saed; Hanan H Balkhy; Hasan M Al-Dorzi; Raymond Khan; Asgar H Rishu; Yaseen M Arabi
Journal:  Int J Infect Dis       Date:  2013-03-19       Impact factor: 3.623

9.  Detection of KPC in Acinetobacter spp. in Puerto Rico.

Authors:  Iraida E Robledo; Edna E Aquino; María I Santé; Jorge L Santana; Diana M Otero; Carlos F León; Guillermo J Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

10.  Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.

Authors:  Hosam M Zowawi; Anna L Sartor; Hanan H Balkhy; Timothy R Walsh; Sameera M Al Johani; Reem Y AlJindan; Mubarak Alfaresi; Emad Ibrahim; Amina Al-Jardani; Seif Al-Abri; Jameela Al Salman; Ali A Dashti; Abdullah H Kutbi; Sanmarié Schlebusch; Hanna E Sidjabat; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

View more
  43 in total

1.  PME-1-producing Pseudomonas aeruginosa in Qatar.

Authors:  Hosam M Zowawi; Emad Ibrahim; Melanie W Syrmis; Alexander M Wailan; Atqah AbdulWahab; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

2.  GES-14-Producing Acinetobacter baumannii Isolates in a Neonatal Intensive Care Unit in Tunisia Are Associated with a Typical Middle East Clone and a Transferable Plasmid.

Authors:  Aymen Mabrouk; Filipa Grosso; João Botelho; Wafa Achour; Assia Ben Hassen; Luisa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

3.  Semi-mechanistic PK/PD modelling of fosfomycin and sulbactam combination against carbapenem-resistant Acinetobacter baumannii.

Authors:  S Mohd Sazlly Lim; A J Heffernan; J A Roberts; F B Sime
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

4.  Complete Genome Sequencing of Acinetobacter baumannii Strain K50 Discloses the Large Conjugative Plasmid pK50a Encoding Carbapenemase OXA-23 and Extended-Spectrum β-Lactamase GES-11.

Authors:  Daniel Wibberg; Ileana P Salto; Felix G Eikmeyer; Irena Maus; Anika Winkler; Patrice Nordmann; Alfred Pühler; Laurent Poirel; Andreas Schlüter
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

5.  Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii.

Authors:  Sazlyna Mohd Sazlly Lim; Aaron J Heffernan; Hosam M Zowawi; Jason A Roberts; Fekade B Sime
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-22       Impact factor: 3.267

6.  Prevalence of antimicrobial resistance in Gram-negative clinical isolates from a major secondary hospital in Kuwait: a retrospective descriptive study.

Authors:  Walid Q Alali; Wadha AlFouzan; Rita Dhar
Journal:  Germs       Date:  2021-12-29

7.  Molecular Surveillance of Multidrug-Resistant Acinetobacter baumannii.

Authors:  Aisha M AlAmri; Ameerah M AlQurayan; Tunny Sebastian; Amani M AlNimr
Journal:  Curr Microbiol       Date:  2019-12-12       Impact factor: 2.188

8.  Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.

Authors:  Adriana Correa; Rosa Del Campo; Kevin Escandón-Vargas; Marcela Perenguez; Mercedes Rodríguez-Baños; Cristhian Hernández-Gómez; Christian Pallares; Federico Perez; Cesar A Arias; Rafael Cantón; María V Villegas
Journal:  Microb Drug Resist       Date:  2017-06-01       Impact factor: 3.431

Review 9.  Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes.

Authors:  Chang-Hua Chen; Li-Chen Lin; Yu-Jun Chang; Yu-Min Chen; Chin-Yen Chang; Chieh-Chen Huang
Journal:  Int J Environ Res Public Health       Date:  2015-07-30       Impact factor: 3.390

10.  Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait.

Authors:  Leila Vali; Khadija Dashti; Andrés F Opazo-Capurro; Ali A Dashti; Khaled Al Obaid; Benjamin A Evans
Journal:  Front Microbiol       Date:  2015-07-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.